Eli Lilly and Co. wants to find out if the antibody drug it has developed can prevent COVID-19 cases in nursing homes, so it is sending mobile research labs to these facilities as part of its late-stage clinical trial. Some labs have been sent to locations across the US in anticipation of COVID-19 outbreaks, and Chief Scientific Officer Dan Skovronsky said that when an outbreak occurs, the mobile lab sets up at the site, works with nursing home staff and randomizes residents and workers into the trial.
Sign up for ANA SmartBrief
Nursing news and information
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.